X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (69653) 69653
Newsletter (3056) 3056
Newspaper Article (1181) 1181
Magazine Article (792) 792
Book Chapter (132) 132
Publication (80) 80
Book / eBook (66) 66
Dissertation (60) 60
Book Review (41) 41
Conference Proceeding (34) 34
Transcript (22) 22
Reference (18) 18
Web Resource (17) 17
Streaming Video (8) 8
Trade Publication Article (2) 2
Archival Material (1) 1
Data Set (1) 1
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (51177) 51177
antihypertensive agents - therapeutic use (36088) 36088
male (32505) 32505
hypertension - drug therapy (31446) 31446
female (27087) 27087
hypertension (24100) 24100
middle aged (21345) 21345
aged (17335) 17335
blood pressure - drug effects (16204) 16204
adult (14736) 14736
animals (13622) 13622
antihypertensive agents - pharmacology (13053) 13053
antihypertensive drugs (12417) 12417
blood pressure (11215) 11215
hypertension - physiopathology (11113) 11113
antihypertensive agents - administration & dosage (9837) 9837
peripheral vascular disease (9249) 9249
risk factors (8744) 8744
pharmacology & pharmacy (8657) 8657
rats (8523) 8523
treatment outcome (8062) 8062
antihypertensive agents - adverse effects (8054) 8054
blood-pressure (7047) 7047
hypertension - complications (6822) 6822
drug therapy, combination (5991) 5991
cardiac & cardiovascular systems (5602) 5602
drug therapy (5523) 5523
medicine, general & internal (5462) 5462
research (4818) 4818
aged, 80 and over (4558) 4558
time factors (4517) 4517
angiotensin-converting enzyme inhibitors - therapeutic use (4472) 4472
mortality (4092) 4092
antihypertensive agents (3880) 3880
care and treatment (3759) 3759
hypertension - diagnosis (3669) 3669
double-blind method (3649) 3649
dose-response relationship, drug (3538) 3538
risk (3524) 3524
hypertension - epidemiology (3445) 3445
prospective studies (3390) 3390
prevalence (3376) 3376
heart rate - drug effects (3299) 3299
follow-up studies (3119) 3119
antihypertensives (3100) 3100
blood pressure - physiology (3081) 3081
calcium channel blockers - therapeutic use (3037) 3037
analysis (3003) 3003
therapy (2836) 2836
health aspects (2823) 2823
management (2790) 2790
prevention (2746) 2746
diuretics (2695) 2695
adrenergic beta-antagonists - therapeutic use (2682) 2682
medicine & public health (2658) 2658
clinical trials as topic (2656) 2656
adolescent (2634) 2634
disease (2589) 2589
ophthalmology (2544) 2544
retrospective studies (2543) 2543
diabetes (2542) 2542
diuretics - therapeutic use (2455) 2455
angiotensin (2451) 2451
rats, inbred shr (2429) 2429
drugs (2411) 2411
randomized controlled trials as topic (2288) 2288
stroke (2281) 2281
hypertension - etiology (2251) 2251
patient compliance (2119) 2119
hemodynamics - drug effects (2103) 2103
internal medicine (2083) 2083
medical research (2081) 2081
urology & nephrology (2066) 2066
prognosis (2024) 2024
antihypertensive therapy (2017) 2017
dosage and administration (1988) 1988
angiotensin receptor antagonists (1962) 1962
hypertension - therapy (1953) 1953
cardiovascular diseases - prevention & control (1944) 1944
cardiovascular disease (1938) 1938
age factors (1932) 1932
abridged index medicus (1890) 1890
losartan (1884) 1884
hypertension, pulmonary - drug therapy (1858) 1858
intraocular pressure - drug effects (1843) 1843
antihypertensive treatment (1832) 1832
rats, sprague-dawley (1829) 1829
pregnancy (1796) 1796
cardiovascular diseases (1792) 1792
drug combinations (1792) 1792
tetrazoles - therapeutic use (1779) 1779
renin-angiotensin system - drug effects (1763) 1763
hypertension - blood (1757) 1757
cross-sectional studies (1743) 1743
medicine, experimental (1731) 1731
double-blind (1730) 1730
cardiology (1694) 1694
angiotensin-converting enzyme inhibitors - pharmacology (1683) 1683
trial (1669) 1669
rats, wistar (1663) 1663
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Baycrest Hospital - Wellness Library (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (67292) 67292
German (2487) 2487
Russian (1589) 1589
French (1532) 1532
Japanese (1263) 1263
Spanish (633) 633
Chinese (443) 443
Portuguese (350) 350
Polish (346) 346
Italian (325) 325
Swedish (167) 167
Czech (156) 156
Danish (146) 146
Norwegian (137) 137
Hungarian (130) 130
Dutch (126) 126
Romanian (65) 65
Ukrainian (61) 61
Croatian (55) 55
Finnish (48) 48
Hebrew (46) 46
Bulgarian (45) 45
Serbian (34) 34
Slovak (31) 31
Turkish (30) 30
Korean (25) 25
Lithuanian (10) 10
Bosnian (4) 4
Slovenian (4) 4
Persian (3) 3
Icelandic (2) 2
Indonesian (2) 2
Arabic (1) 1
Armenian (1) 1
Greek (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2018, Volume 2018, Issue 4, p. CD001841
...: What class of drug to use first‐line? This review attempted to answer that question. Objectives To quantify the mortality and morbidity effects from different first... 
Hypertension | Kidney disease | Treatment: pharmacological | Stroke | Sodium Chloride Symporter Inhibitors | Pharmacological Therapies | Angiotensin‐Converting Enzyme Inhibitors | Randomized Controlled Trials as Topic | General Pharmacotherapies | Calcium Channel Blockers | Coronary Disease | Adrenergic beta‐Antagonists | Antihypertensive Agents | Heart & circulation | Thiazides | Medicine General & Introductory Medical Sciences | Treatment of essential Hypertension | Angiotensin-Converting Enzyme Inhibitors [therapeutic use] | Antihypertensive Agents [adverse effects; therapeutic use] | Coronary Disease [prevention & control] | Humans | ELDERLY PROGRAM SHEP | CONVERTING-ENZYME-INHIBITION | Sodium Chloride Symporter Inhibitors [therapeutic use] | Adrenergic beta-Antagonists [therapeutic use] | EUROPEAN-WORKING-PARTY | PROSPECTIVELY-DESIGNED OVERVIEWS | Calcium Channel Blockers [therapeutic use] | SERUM URIC-ACID | MEDICINE, GENERAL & INTERNAL | AUSTRALIAN THERAPEUTIC TRIAL | HIGH-BLOOD-PRESSURE | ISOLATED SYSTOLIC HYPERTENSION | PLACEBO-CONTROLLED TRIAL | Stroke [prevention & control] | CORONARY-HEART-DISEASE | Hypertension [drug therapy; mortality] | Stroke - prevention & control | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Sodium Chloride Symporter Inhibitors - therapeutic use | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Thiazides - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypertension - mortality | Adrenergic beta-Antagonists - therapeutic use | Thiazides - therapeutic use
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
.... We aimed to assess use of proven effective secondary preventive drugs (antiplatelet drugs, β... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 11/2018, Volume 2018, Issue 11, p. CD008170
.... Despite widespread use for hypertension, the efficacy and safety of RAS inhibitors compared to other antihypertensive drug classes remains unclear... 
Hypertension | Kidney disease | Stroke | Renin‐Angiotensin System | Sodium Chloride Symporter Inhibitors | Cause of Death | Angiotensin‐Converting Enzyme Inhibitors | Randomized Controlled Trials as Topic | Calcium Channel Blockers | Myocardial Infarction | Management/treatment of Specific sub‐types of Hypertensive Patients | Management of specific sub‐types of hypertensive patients | Heart Failure | Kidney Failure, Chronic | Antihypertensive Agents | Heart & circulation | Medicine General & Introductory Medical Sciences | Treatment of essential Hypertension | Patients with other cardiovascular risk factors (smoking; diabetes; high serum cholesterol levels; arterial fibrillation) | CALCIUM-CHANNEL BLOCKER | INTIMA-MEDIA THICKNESS | LIPID-LOWERING TREATMENT | DEPENDENT DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | END-POINT REDUCTION | CONVERTING ENZYME-INHIBITION | DOUBLE-BLIND | BLOOD-PRESSURE CONTROL | QUALITY-OF-LIFE | LEFT-VENTRICULAR HYPERTROPHY | Myocardial Infarction - epidemiology | Stroke - prevention & control | Calcium Channel Blockers - adverse effects | Humans | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Heart Failure - prevention & control | Stroke - chemically induced | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Kidney Failure, Chronic - epidemiology | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Renin-Angiotensin System - drug effects | Aged | Hypertension - mortality | Heart Failure - chemically induced | Heart Failure - mortality
Journal Article
Advances in Therapy, ISSN 0741-238X, 5/2015, Volume 32, Issue 5, pp. 404 - 417
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 03/2006, Volume 113, Issue 9, pp. 1213 - 1225
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 05/2009, Volume 53, Issue 5, pp. 860 - 866
.... Patients on long-term dialysis participating in randomized, controlled trials and receiving antihypertensive drug therapy were the subject of this meta-analysis... 
Hypertension | Cardiovascular events | Systematic review | Treatment | Hemodialysis | Reverse epidemiology | cardiovascular events | SURVIVAL | treatment | EVENTS | MORTALITY RISK | BIAS | DEATH | reverse epidemiology | systematic review | hemodialysis | HEMODIALYSIS-PATIENTS | BLOOD-PRESSURE CONTROL | PERIPHERAL VASCULAR DISEASE